Get the Stockscreener App
0.9829
1.71%
-0.0171
Pre-market:
.99
0.0071
+0.72%
Canopy Growth Corporation stock is traded at $0.9829, with a volume of 14.31M.
It is down -1.71% in the last 24 hours and down -5.49% over the past month.
Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, Bedrocan Canada, CraftGrow, and Foria brand names. It also offers its products through Tweed Main Street, a single online platform that enables registered patients to purchase medicinal cannabis from various producers across various brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
See More
Previous Close:
$1.00
Open:
$0.9949
24h Volume:
14.31M
Relative Volume:
1.46
Market Cap:
$415.59M
Revenue:
$199.30M
Net Income/Loss:
$-230.47M
P/E Ratio:
-0.7625
EPS:
-1.2891
Net Cash Flow:
$-58.89M
1W Performance:
-3.64%
1M Performance:
-5.49%
6M Performance:
-40.79%
1Y Performance:
-33.59%
1-Day Range:
$0.961
$1.04
1-Week Range:
$0.961
$1.09
52-Week Range:
$0.8435
$2.38
Canopy Growth Corporation Stock (CGC) Company Profile
Name
Canopy Growth Corporation
Sector
Phone
855-558-9333
Address
1 Hershey Drive, Smiths Falls, ON
Compare CGC vs TAK, HLN, TEVA, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CGC
Canopy Growth Corporation
|
0.9829 | 415.59M | 199.30M | -230.47M | -58.89M | -1.2891 |
TAK
Takeda Pharmaceutical Co Adr
|
15.77 | 49.83B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.07 | 40.04B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
33.69 | 39.23B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
79.95 | 33.52B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
549.57 | 23.33B | 3.17B | 1.29B | 1.01B | 27.09 |
Canopy Growth Corporation Stock (CGC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-27-26 | Initiated | Canaccord Genuity | Buy |
| Nov-10-25 | Upgrade | The Benchmark Company | Sell → Hold |
| Apr-04-23 | Upgrade | Bernstein | Underperform → Mkt Perform |
| Nov-02-22 | Initiated | Bernstein | Underperform |
| Oct-26-22 | Upgrade | Canaccord Genuity | Sell → Hold |
| Jun-08-22 | Downgrade | BMO Capital Markets | Market Perform → Underperform |
| Mar-22-22 | Downgrade | Barclays | Equal Weight → Underweight |
| Dec-22-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Dec-20-21 | Downgrade | Piper Sandler | Neutral → Underweight |
| Dec-07-21 | Initiated | Wells Fargo | Underweight |
| Nov-18-21 | Initiated | Barclays | Equal Weight |
| Nov-08-21 | Downgrade | CIBC | Neutral → Sector Underperform |
| Nov-08-21 | Downgrade | Canaccord Genuity | Hold → Sell |
| Nov-08-21 | Downgrade | Cowen | Outperform → Market Perform |
| Oct-01-21 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-12-21 | Upgrade | Jefferies | Underperform → Hold |
| Jun-02-21 | Upgrade | Canaccord Genuity | Sell → Hold |
| May-25-21 | Upgrade | MKM Partners | Neutral → Buy |
| Apr-28-21 | Resumed | BofA Securities | Buy |
| Feb-24-21 | Downgrade | Jefferies | Hold → Underperform |
| Feb-10-21 | Downgrade | Canaccord Genuity | Hold → Sell |
| Feb-10-21 | Downgrade | The Benchmark Company | Buy → Hold |
| Feb-05-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-04-20 | Upgrade | CFRA | Buy → Strong Buy |
| Jun-01-20 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Jun-01-20 | Downgrade | Bryan Garnier | Neutral → Sell |
| Jun-01-20 | Downgrade | CIBC | Sector Outperform → Neutral |
| Jun-01-20 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Jun-01-20 | Downgrade | Stifel | Buy → Sell |
| May-22-20 | Resumed | BofA/Merrill | Buy |
| Apr-16-20 | Upgrade | Jefferies | Underperform → Hold |
| Jan-28-20 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Dec-12-19 | Reiterated | Cantor Fitzgerald | Neutral |
| Nov-20-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Nov-15-19 | Downgrade | Alliance Global Partners | Buy → Neutral |
| Nov-05-19 | Initiated | Cantor Fitzgerald | Neutral |
| Oct-14-19 | Downgrade | Seaport Global Securities | Buy → Neutral |
| Oct-11-19 | Downgrade | Jefferies | Hold → Underperform |
| Sep-27-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Sep-20-19 | Initiated | MKM Partners | Neutral |
| Sep-18-19 | Initiated | Oppenheimer | Perform |
| Aug-26-19 | Upgrade | Seaport Global Securities | Neutral → Buy |
| Jul-17-19 | Initiated | Ladenburg Thalmann | Buy |
View All
Canopy Growth Corporation Stock (CGC) Latest News
Where Will Canopy Growth Be in 5 Years? - Yahoo Finance
Why Is Canopy Growth in Focus on NYSE Composite Amid Shifts? - Kalkine Media
Canopy Growth reports big jump in medical cannabis revenue - MJBizDaily
CGC Projects Revenue Growth and Positive EBITDA by FY2027 - GuruFocus
Canopy Growth Restates Past Financials, Reports FY2026 Net Loss of $154.7M - StratCann
Canopy Growth Reports 300.0% Wider Q4 2026 Loss at -$0.40/Share - AlphaStreet
Canopy Growth Releases Q4 2026 Financial Results - AlphaStreet
Canopy Growth revenue climbs 14% in Q4 - Proactive financial news
Earnings call transcript: Canopy Growth misses Q4 2026 estimates as cash improves - Investing.com
Canopy Growth narrow losses, reports net cash position for FY26 - grafa.com
Canopy Growth Corporation - Baystreet.ca
Canopy Growth Q4 Earnings Call Highlights - MarketBeat
Canopy Growth (CGC) Surges on Optimism from DEA Rescheduling - GuruFocus
CGC Reports Strong Q4 Revenue Growth and Future Expansion Plans - GuruFocus
Canopy Growth Corporation Reports Earnings Results for the Fourth Quarter Ended March 31, 2026 - marketscreener.com
Is Canopy Growth Corp (CGC) Overvalued After Q4 Earnings Miss? E - GuruFocus
Canopy Growth Corporation (CGC) Sees Positive Momentum Amid Cann - GuruFocus
Canopy Growth Corporation (CGC) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance
Canopy Growth Reports FY2026: Net Revenue C$284.6M, Q4 Net Revenue C$71.2M, Net Cash C$131.3M - TradingView
Earnings Scheduled For June 15, 2026 - Benzinga
Earnings Flash (WEED.TO) Canopy Growth Net Loss From Continuing Ops in Q4 FY2026 Was 21% Lower Xompared to Q4 FY2025 - marketscreener.com
WEED: Q4 FY2026 net revenue up 10% YoY; full-year net loss narrowed by 49% with improved cash position - TradingView
Canopy Growth (CGC) Misses Q4 EPS by 32c - StreetInsider
Canopy Growth (NASDAQ: CGC) halves FY2026 net loss and boosts revenue - Stock Titan
Canopy Growth Reports Consolidated Net Revenue of $71.2M in Q4 FY2026 - marketscreener.com
Canopy Growth Corp 2026 Annual Report: Business Segments, Equity, and Financial Statements Overview - Minichart
BRIEF-Canopy Growth Corp Q4 Revenue CAD 84.69 Million Vs. IBES Estimate CAD 74.4 Million - TradingView
Canopy Growth trims free cash outflow, expects positive adjusted EBITDA in 2027 - Stock Titan
Canopy Growth Corp FY Result — 10-K Summary - TradingView
WEED: Revenue grew 6% in FY26, net loss narrowed, and liquidity improved after recapitalization - TradingView
Restatement, control issues and new debt reshape Canopy Growth (NASDAQ: CGC) - Stock Titan
Canopy Growth (CGC) Set to Release FQ4 Earnings Amid Financial R - GuruFocus
Earnings week ahead: KR, ACN, CGC, JBL, and more - Seeking Alpha
Canopy Growth (CGC) Set to Report Q4 Earnings with Improved Loss Expectations - GuruFocus
Canopy Growth earnings preview: Can cost cuts keep narrowing losses? - MSN
Canopy Growth earnings preview: Can cost cuts keep narrowing losses? (CGC:NASDAQ) - Seeking Alpha
Canopy Growth Corporation (CGC) is a trending stock: Facts to know before betting on it - MSN
Cannabis Stocks On TSX Show New Quality Signals - Kalkine Media
Trulieve Makes History As First US Cannabis Stock On NYSE - Benzinga
Why Are Cannabis Stocks Shifting With Sector Rotation in June? - Kalkine Media
Canopy Growth Just Made a Big Acquisition: Game-Changer -- or Another Misstep? - AOL.com
Tilray Brands Sparks Fresh Cannabis Reform Buzz - Kalkine Media
Canopy Growth Announces Claybourne’s Frosted Flyers Wins ‘Best Infused Pre-Roll' at 2026 Grow Up Awards - Canopy Growth
AKAN Stock Leaves Cannabis Peers In The Smoke With A Stunning 1,700% Rally In April — What’s Fueling The Run? - Stocktwits
Canopy Growth stock drops 3.37% as shares trade below key averages - Traders Union
What’s Driving Fresh Attention Toward Canopy Growth? - Kalkine Media
Cannabis Stocks And TSX Rotation: What Could Drive Momentum Next? - Kalkine Media
TSX Cannabis Stocks Gain Focus Amid Shifting Market Conditions - Kalkine Media
StockTalk | Cannabis Report: Mid-year checkup | 2026-06-05 | Investing News - Stockhouse
Canopy Growth Corporation (CGC) is attracting investor attention: Here is what you should know - MSN
Canopy Growth Corporation (CGC) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Canopy Growth Corporation Stock (CGC) Financials Data
Revenue
Net Income
Cash Flow
EPS
9.24%
0.23%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):